BioCentury | Nov 28, 2018
Company News

Management tracks: PolarityTE and Foamix hire first chief commercial officers

...newly created position. He was CCO at Dendreon Pharmaceuticals LLC, now owned by Chinese conglomerate Sanpower Group Co. Ltd....
BioCentury | May 25, 2018
Clinical News

Dendreon takes Provenge earlier in prostate cancer

...Dendreon is owned by Chinese conglomerate Sanpower Group Co. Ltd. (Nanjing, China). Dendreon Pharmaceuticals LLC, Seal Beach, Calif. Sanpower Group Co. Ltd....
...years after treatment Status: Phase III start (4Q18) Milestone: Phase III data (2023) Emily Cukier-Meisner Provenge, sipuleucel-t (APC8015) Dendreon Sanpower Group Co. Ltd....
BioCentury | May 18, 2018
Clinical News

Dendreon takes Provenge earlier in prostate cancer

...will be appropriate. Dendreon is owned by Chinese conglomerate Sanpower Group Co. Ltd. (Nanjing, China). Emily Cukier-Meisner Provenge, sipuleucel-t (APC8015) Dendreon Corp. Sanpower Group Co. Ltd....
BioCentury | Mar 10, 2018
Product Development

Defining progress

...instead he’d prescribe Provenge sipuleucel-T or chemotherapy for patients who progress on Erleada. Provenge is Sanpower Group Co. Ltd.’s...
...HSE:ORNBV), Espoo, Finland Pfizer Inc. (NYSE:PFE), New York, N.Y. Prostate Cancer Foundation, Santa Monica, Calif. Sanpower Group Co. Ltd....
BioCentury | Nov 10, 2017
Company News

Management tracks: Immunomedics, WuXi

...was senior medical director of oncology at Astellas Pharma Inc. (Tokyo:4503). Dendreon was acquired by Sanpower Group Co. Ltd....
BioCentury | Jul 6, 2017
Company News

Sanpower completes acquisition of Dendreon from Valeant

...Asia. Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Laval, Quebec Sanpower Group Co. Ltd. , Nanjing, China Business: Cancer Meghan Sullivan Provenge sipuleucel-T Sanpower Group Co. Ltd. Valeant...
BioCentury | Jun 30, 2017
Company News

Sanpower completes Dendreon acquisition

...the continuity of Dendreon's U.S. team and will promote Provenge in China and Southeast Asia. Mary Romeo Provenge Sanpower Group Co. Ltd. Valeant...
BioCentury | Jan 13, 2017
Company News

Valeant, Sanpower deal

...Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Laval, Quebec Sanpower Group Co. Ltd., Nanjing, China Business: Cancer Chris Lieu Provenge Dendreon Valeant Pharmaceuticals International Inc. Sanpower Group Co. Ltd....
BioCentury | Jan 10, 2017
Company News

Valeant selling Dendreon to Chinese conglomerate

...Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) is selling cancer company Dendreon Pharmaceuticals Inc. to Sanpower Group Co. Ltd. (Nanjing...
...phosphatase and an immunostimulatory cytokine (see BioCentury Extra, Feb. 23, 2015) . Chris Lieu Provenge Dendreon Valeant Pharmaceuticals International Inc. Sanpower Group Co. Ltd....
Items per page:
1 - 9 of 9
BioCentury | Nov 28, 2018
Company News

Management tracks: PolarityTE and Foamix hire first chief commercial officers

...newly created position. He was CCO at Dendreon Pharmaceuticals LLC, now owned by Chinese conglomerate Sanpower Group Co. Ltd....
BioCentury | May 25, 2018
Clinical News

Dendreon takes Provenge earlier in prostate cancer

...Dendreon is owned by Chinese conglomerate Sanpower Group Co. Ltd. (Nanjing, China). Dendreon Pharmaceuticals LLC, Seal Beach, Calif. Sanpower Group Co. Ltd....
...years after treatment Status: Phase III start (4Q18) Milestone: Phase III data (2023) Emily Cukier-Meisner Provenge, sipuleucel-t (APC8015) Dendreon Sanpower Group Co. Ltd....
BioCentury | May 18, 2018
Clinical News

Dendreon takes Provenge earlier in prostate cancer

...will be appropriate. Dendreon is owned by Chinese conglomerate Sanpower Group Co. Ltd. (Nanjing, China). Emily Cukier-Meisner Provenge, sipuleucel-t (APC8015) Dendreon Corp. Sanpower Group Co. Ltd....
BioCentury | Mar 10, 2018
Product Development

Defining progress

...instead he’d prescribe Provenge sipuleucel-T or chemotherapy for patients who progress on Erleada. Provenge is Sanpower Group Co. Ltd.’s...
...HSE:ORNBV), Espoo, Finland Pfizer Inc. (NYSE:PFE), New York, N.Y. Prostate Cancer Foundation, Santa Monica, Calif. Sanpower Group Co. Ltd....
BioCentury | Nov 10, 2017
Company News

Management tracks: Immunomedics, WuXi

...was senior medical director of oncology at Astellas Pharma Inc. (Tokyo:4503). Dendreon was acquired by Sanpower Group Co. Ltd....
BioCentury | Jul 6, 2017
Company News

Sanpower completes acquisition of Dendreon from Valeant

...Asia. Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Laval, Quebec Sanpower Group Co. Ltd. , Nanjing, China Business: Cancer Meghan Sullivan Provenge sipuleucel-T Sanpower Group Co. Ltd. Valeant...
BioCentury | Jun 30, 2017
Company News

Sanpower completes Dendreon acquisition

...the continuity of Dendreon's U.S. team and will promote Provenge in China and Southeast Asia. Mary Romeo Provenge Sanpower Group Co. Ltd. Valeant...
BioCentury | Jan 13, 2017
Company News

Valeant, Sanpower deal

...Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Laval, Quebec Sanpower Group Co. Ltd., Nanjing, China Business: Cancer Chris Lieu Provenge Dendreon Valeant Pharmaceuticals International Inc. Sanpower Group Co. Ltd....
BioCentury | Jan 10, 2017
Company News

Valeant selling Dendreon to Chinese conglomerate

...Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) is selling cancer company Dendreon Pharmaceuticals Inc. to Sanpower Group Co. Ltd. (Nanjing...
...phosphatase and an immunostimulatory cytokine (see BioCentury Extra, Feb. 23, 2015) . Chris Lieu Provenge Dendreon Valeant Pharmaceuticals International Inc. Sanpower Group Co. Ltd....
Items per page:
1 - 9 of 9